Vialize V1
Vialize V1

The Next Generation Placental Membrane Allograft for Hospital Use

Vialize, a lyophilized dehydrated complete human placental membrane (dCHPM) allograft, is designed for use as a wound covering or barrier membrane. Unlike many other placental allografts that typically contain one or two layers of the placental membrane, Vialize retains all three layers of the membrane using the patented Clearify® technology.1 Vialize allografts are never delaminated allowing for optimal preservation of the 3D architecture of the native tissue.

Product Images Website-02

4x thicker, 6x more growth factors, 4x more protein than the competitor graft1,2

Easy to handle and apply

Retains key structural components and proteins1

Case Reports

Common Clinical Applications

Procedure Types
  • Amputations
  • Hysterectomies
  • Lumbar & Cervical Fusions
  • Myomectomies
  • Surgical Wounds
  • Tendon & Ligament Repairs
  • Traumatic Wounds
  • Ulcers

Specialties

  • General Surgery
  • OBGYN
  • Orthopedic Surgery
  • Plastic Surgery
  • Podiatry
  • Spine & Neurosurgery
  • Vascular Surgery

Video Gallery

Robotic Laparoscopic Myomectomy with Placement of Lyophilized dCHPM Allograft

Sizes and SKUs

VL Box
Size
2 x 3 cm
4 x 4 cm
4x6 cm
6x8 cm
2 x 12 cm
SKU VL-2030 VL-4040 VL-4060 VL-6080 VL-0212

Sheet format: Shelf-stable for up to five (5) years

Box symbols

Vialize is intended to be used as a wound covering or barrier membrane. Vialize complements standard of care as a barrier membrane following primary repair or closure. 1. Data on file. 2. Data is compared to the leading dual-layer allograft and reported as an average. Patents: www.stimlabs.com/patents